相关实验视频
Updated: Jun 6, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
孕妇患有1型糖尿病的低血糖:这是不可避免的吗?
Barak M Rosenn1, Jane C Khoury2,3,4, Francis Mimouni5
1Department of Obstetrics, Gynecology, and Reproductive Health, Rutgers New Jersey Medical School, Jersey City Medical Center, Jersey City, New Jersey.
患有1型糖尿病的人往往不会意识到低血糖. 患有1型糖尿病的孕妇面临更高的严重低血糖风险,但新的胰岛素技术可能有助于管理这种情况.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 生殖健康 生殖健康
背景情况:
- 1型糖尿病 (T1D) 损害了身体对低血糖 (低血糖症) 的自然防御能力,并对这些发作缺乏意识.
- 患有T1D的孕妇特别容易患上严重的低血糖症,特别是在怀孕早期,由于荷尔蒙变化和逆调节反应减弱.
- 虽然怀孕早期的严重低血糖症似乎不会增加流产或出生缺陷的风险,但对胎儿的长期影响仍然是未知的.
研究的目的:
- 审查患有T1D的孕妇低血糖症的风险和管理.
- 要突出怀孕对T1D中低血糖的逆调节反应的影响.
- 讨论新兴技术在减轻怀孕期间低血糖风险方面的作用.
主要方法:
- 对低血糖,T1D和怀孕的当前文献的综述.
- 对怀孕和非怀孕的T1D患者低血糖的生理反应的分析.
- 评估糖尿病管理的技术进步,包括胰岛素类似物,持续血糖监测和闭环系统.
主要成果:
- 患有T1D的个体经历了相反调节反应的减少和低血糖不意识.
- 怀孕加剧了T1D的低血糖风险,特别是在头三个月.
- 先进的糖尿病技术显示出降低T1D孕妇低血糖的潜力.
结论:
- 患有T1D的孕妇需要谨慎管理,以预防严重的低血糖症.
- 技术进步为改善血糖控制和降低怀孕期间低血糖风险提供了潜在的解决方案.
- 需要进行进一步的研究,以优化这些技术在T1D孕妇群体中的使用.
更多相关视频
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...